Microfluidic platforms for biomarker analysis.

Biomarkers have been described as characteristics, most often molecular, that provide information about biological states, whether normal, pathological, or therapeutically modified. They hold great potential to assist diagnosis and prognosis, monitor disease, and assess therapeutic effectiveness. While a few biomarkers are routinely utilised clinically, these only reflect a very small percentage of all biomarkers discovered. Numerous factors contribute to the slow uptake of these new biomarkers, with challenges faced throughout the biomarker development pipeline. Microfluidics offers two important opportunities to the field of biomarkers: firstly, it can address some of these developmental obstacles, and secondly, it can provide the precise and complex platform required to bridge the gap between biomarker research and the biomarker-based analytical device market. Indeed, adoption of microfluidics has provided a new avenue for advancement, promoting clinical utilisation of both biomarkers and their analytical platforms. This review will discuss biomarkers and outline microfluidic platforms developed for biomarker analysis.

[1]  Tza-Huei Wang,et al.  Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy. , 2010, Journal of the American Chemical Society.

[2]  S. Kaufmann,et al.  The quest for biomarkers in tuberculosis. , 2010, Drug discovery today.

[3]  Jin Sheng,et al.  Fabrication of tunable microreactor with enzyme modified magnetic nanoparticles for microfluidic electrochemical detection of glucose. , 2012, Analytica chimica acta.

[4]  E. Drucker,et al.  Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine , 2013, EPMA Journal.

[5]  Ali Khademhosseini,et al.  A mini-microscope for in situ monitoring of cells. , 2012, Lab on a chip.

[6]  Shenguang Ge,et al.  Paper-based electrochemiluminescent 3D immunodevice for lab-on-paper, specific, and sensitive point-of-care testing. , 2012, Chemistry.

[7]  D. Sargent,et al.  Biomarkers and surrogate end points—the challenge of statistical validation , 2010, Nature Reviews Clinical Oncology.

[8]  R. Corn,et al.  Rapid microarray detection of DNA and proteins in microliter volumes with surface plasmon resonance imaging measurements. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[9]  D. Kerr,et al.  Predictive biomarkers: a paradigm shift towards personalized cancer medicine , 2011, Nature Reviews Clinical Oncology.

[10]  N. Sattar.  Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[11]  Walter Artibani,et al.  Landmarks in prostate cancer diagnosis: the biomarkers , 2012, BJU international.

[12]  Joseph Wang.  Electrochemical glucose biosensors. , 2008, Chemical reviews.

[13]  Julian M. W. Quinn,et al.  Cord Blood-Derived Macrophage-Lineage Cells Rapidly Stimulate Osteoblastic Maturation in Mesenchymal Stem Cells in a Glycoprotein-130 Dependent Manner , 2013, PloS one.

[14]  Mary Cushman,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. , 2009, Clinical chemistry.

[15]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[16]  M. Parrish,et al.  Novel Tissue Types for the Development of Genomic Biomarkers , 2012 .

[17]  Á. Ríos,et al.  Miniaturization through lab-on-a-chip: utopia or reality for routine laboratories? A review. , 2012, Analytica chimica acta.

[18]  N. Frangogiannis,et al.  Biomarkers: hopes and challenges in the path from discovery to clinical practice. , 2012, Translational research : the journal of laboratory and clinical medicine.

[19]  Ming-Chun Huang,et al.  Rapid electrochemical detection on a mobile phone. , 2013, Lab on a chip.

[20]  A. Schacht,et al.  Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal , 2013, Malaria Journal.

[21]  Wei Shen,et al.  Quantitative biomarker assay with microfluidic paper-based analytical devices , 2010, Analytical and bioanalytical chemistry.

[22]  S. Tejpar,et al.  Clinical Biomarkers in Oncology Focus on Colorectal Cancer , 2012 .

[23]  James F Rusling,et al.  Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. , 2011, Biosensors & bioelectronics.

[24]  F. Blasi,et al.  Biomarkers in lower respiratory tract infections. , 2010, Pulmonary pharmacology & therapeutics.

[25]  M. Mascini,et al.  Aptamer-based detection of plasma proteins by an electrochemical assay coupled to magnetic beads. , 2007, Analytical chemistry.

[26]  N. Rifai,et al.  Commercial immunoassays in biomarkers studies: researchers beware! , 2013, Clinical chemistry and laboratory medicine.

[27]  S. Liska,et al.  Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[28]  R. John,et al.  Nanostructured anatase-titanium dioxide based platform for application to microfluidics cholesterol biosensor , 2012 .

[29]  Alissa K. Greenberg,et al.  Biomarkers for lung cancer: clinical uses , 2007, Current opinion in pulmonary medicine.

[30]  M. Wirth,et al.  Surface modification of the channels of poly(dimethylsiloxane) microfluidic chips with polyacrylamide for fast electrophoretic separations of proteins. , 2004, Analytical chemistry.

[31]  D. Erickson,et al.  Smartphone based health accessory for colorimetric detection of biomarkers in sweat and saliva. , 2013, Lab on a chip.

[32]  Konstantinos Mitsakakis,et al.  Detection of multiple cardiac markers with an integrated acoustic platform for cardiovascular risk assessment. , 2011, Analytica chimica acta.

[33]  Gengfeng Zheng,et al.  Multiplexed electrical detection of cancer markers with nanowire sensor arrays , 2005, Nature Biotechnology.

[34]  M. Perkins,et al.  New developments in malaria diagnostics , 2012, mAbs.

[35]  Edd Fleming,et al.  The microeconomics of personalized medicine: today's challenge and tomorrow's promise , 2009, Nature Reviews Drug Discovery.

[36]  U. Schaff,et al.  Whole blood immunoassay based on centrifugal bead sedimentation. , 2011, Clinical chemistry.

[37]  M. Duffy,et al.  Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. , 2007, European journal of cancer.

[38]  R. Zengerle,et al.  Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. , 2010, Chemical Society reviews.

[39]  Yen-Heng Lin,et al.  Integrating solid-state sensor and microfluidic devices for glucose, urea and creatinine detection based on enzyme-carrying alginate microbeads. , 2013, Biosensors & bioelectronics.

[40]  A. Fernie,et al.  Metabolite profiling: from diagnostics to systems biology , 2004, Nature Reviews Molecular Cell Biology.

[41]  C. Sawyers.  The cancer biomarker problem , 2008, Nature.

[42]  Prashanta Dutta,et al.  10,000-fold concentration increase of the biomarker cardiac troponin I in a reducing union microfluidic chip using cationic isotachophoresis. , 2011, Lab on a chip.

[43]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[44]  D. Burgess.  Gene Expression: One size does not fit all for transcriptomes , 2011, Nature Reviews Genetics.

[45]  Donald Wlodkowic,et al.  Immunology on chip: promises and opportunities. , 2014, Biotechnology advances.

[46]  A. Cowman,et al.  Identification and Prioritization of Merozoite Antigens as Targets of Protective Human Immunity to Plasmodium falciparum Malaria for Vaccine and Biomarker Development , 2013, The Journal of Immunology.

[47]  Andrew J. Vickers,et al.  Prostate-specific antigen and prostate cancer: prediction, detection and monitoring , 2008, Nature Reviews Cancer.

[48]  A. Meguerditchian,et al.  Biomarkers and targeted therapeutics in colorectal cancer. , 2013, Surgical oncology clinics of North America.

[49]  Nader Rifai,et al.  What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema , 2010, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[50]  C. Cooper,et al.  The Present and Future of Prostate Cancer Urine Biomarkers , 2013, International journal of molecular sciences.

[51]  Hye-Jin Sung,et al.  Biomarkers for the lung cancer diagnosis and their advances in proteomics. , 2008, BMB reports.

[52]  K. Killeen,et al.  Profile of native N‐linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time‐of‐flight mass spectrometry , 2009, Proteomics.

[53]  Pae C. Wu,et al.  Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine , 2014, Critical reviews in biotechnology.

[54]  Bradford C. Dickerson,et al.  Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau , 2013, Front. Aging Neurosci..

[55]  Alimuddin Zumla,et al.  Tuberculosis 2013 : 2 Tuberculosis biomarkers discovery : developments , needs , and challenges , 2013 .

[56]  J. Childerhose,et al.  Health consumption as work: the home pregnancy test as a domesticated health tool. , 2013, Social science & medicine.

[57]  J. Schalken,et al.  Personalized Management in Low-Risk Prostate Cancer: The Role of Biomarkers , 2012, Prostate cancer.

[58]  R. Olsen,et al.  Lung cancer biomarkers: present status and future developments. , 2013, Archives of pathology & laboratory medicine.

[59]  M. Tainsky,et al.  Genomic and proteomic biomarkers for cancer: a multitude of opportunities. , 2009, Biochimica et biophysica acta.

[60]  Kak Namkoong,et al.  Surface acoustic wave immunosensor for real-time detection of hepatitis B surface antibodies in whole blood samples. , 2009, Biosensors & bioelectronics.

[61]  M. Dowsett,et al.  Biomarkers for the clinical management of breast cancer: International perspective , 2013, International journal of cancer.

[62]  Ming Yu,et al.  Multilayer polymer microchip capillary array electrophoresis devices with integrated on-chip labeling for high-throughput protein analysis. , 2011, Analytical chemistry.

[63]  S. Engelborghs,et al.  The value of cerebrospinal fluid biomarkers for the differential diagnosis of dementia , 2012 .

[64]  Kelvin J. Liu,et al.  A surface topography assisted droplet manipulation platform for biomarker detection and pathogen identification. , 2011, Lab on a chip.

[65]  B. McManus,et al.  The Human Serum Metabolome , 2011, PloS one.

[66]  David J. Mooney,et al.  Label-free biomarker detection from whole blood , 2009, 2010 10th IEEE International Conference on Solid-State and Integrated Circuit Technology.

[67]  P. Carroll,et al.  Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients. , 2011, Cancer research.

[68]  P. Wei,et al.  Magnetic nanoparticle-enhanced SPR on gold nanoslits for ultra-sensitive, label-free detection of nucleic acid biomarkers. , 2013, The Analyst.

[69]  M. Grayson,et al.  Point‐of‐care tests for lower respiratory tract infections , 2007, The Medical journal of Australia.

[70]  V. V. Empel,et al.  Circulating miRNAs: Reflecting or Affecting Cardiovascular Disease? , 2012, Current Hypertension Reports.

[71]  Catherine Situma,et al.  Merging microfluidics with microarray-based bioassays. , 2006, Biomolecular engineering.

[72]  G. Poste.  Bring on the biomarkers , 2011, Nature.

[73]  J. Weinstein,et al.  Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.

[74]  R. Zengerle,et al.  Towards a “Sample-In, Answer-Out” Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System , 2011, Journal of oncology.

[75]  Nathan A. Pugh,et al.  Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. , 2009, Chest.

[76]  H. Yoo,et al.  High throughput cell cycle analysis using microfluidic image cytometry (μFIC) , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[77]  Noritada Kaji,et al.  Immuno-pillar chip: a new platform for rapid and easy-to-use immunoassay. , 2010, Lab on a chip.

[78]  L. F. Waanders,et al.  Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses , 2013, PloS one.

[79]  M. Duffy,et al.  Serum tumor markers in breast cancer: are they of clinical value? , 2006, Clinical chemistry.

[80]  K. Silamut,et al.  Evaluation of a PfHRP2 and a pLDH-based Rapid Diagnostic Test for the Diagnosis of Severe Malaria in 2 Populations of African Children , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  N. Majkić-Singh.  What is a Biomarker? From its Discovery to Clinical Application , 2011 .

[82]  Juan G Santiago,et al.  Integration of on-chip isotachophoresis and functionalized hydrogels for enhanced-sensitivity nucleic acid detection. , 2012, Analytical chemistry.

[83]  Mehmet Toner,et al.  Clinical Microfluidics for Neutrophil Genomics and Proteomics , 2010, Nature Medicine.

[84]  Chengcheng Liu,et al.  Microfluidic chip-based aptasensor for amplified electrochemical detection of human thrombin , 2010 .

[85]  C. Sigman,et al.  Cancer biomarkers: selecting the right drug for the right patient , 2012, Nature Reviews Drug Discovery.

[86]  P. Vineis,et al.  Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. , 2007, Mutation research.

[87]  L. Fu,et al.  Rapid glucose concentration detection utilizing disposable integrated microfluidic chip , 2011 .

[88]  Tae-Hyeong Kim,et al.  Lab-on-a-disc for fully integrated multiplex immunoassays. , 2012, Analytical Chemistry.

[89]  L. Joosten,et al.  Combination of biomarkers for the discrimination between bacterial and viral lower respiratory tract infections. , 2012, The Journal of infection.

[90]  Ricardo Femat,et al.  Development of an optimized multi-biomarker panel for the detection of lung cancer based on principal component analysis and artificial neural network modeling , 2012, Expert Syst. Appl..

[91]  Chaoyong James Yang,et al.  Massively parallel single-molecule and single-cell emulsion reverse transcription polymerase chain reaction using agarose droplet microfluidics. , 2012, Analytical chemistry.

[92]  James F Rusling,et al.  Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array. , 2012, Analytical chemistry.

[93]  Ruedi Aebersold,et al.  Perspective: a program to improve protein biomarker discovery for cancer. , 2005, Journal of proteome research.

[94]  Y. K. Cheung,et al.  1 Supplementary Information for : Microfluidics-based diagnostics of infectious diseases in the developing world , 2011 .

[95]  M. Verma,et al.  Biomarkers in Prostate Cancer Epidemiology , 2011, Cancers.

[96]  John Gohring,et al.  Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor , 2010 .

[97]  Zhike He,et al.  Determination of glucose and uric acid with bienzyme colorimetry on microfluidic paper-based analysis devices. , 2012, Biosensors & bioelectronics.

[98]  Jin Jen,et al.  Quantitative miRNA Expression Analysis Using Fluidigm Microfluidics Dynamic Arrays , 2011, BMC Genomics.

[99]  George Poste,et al.  Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards. , 2012, Trends in molecular medicine.

[100]  Hongying Zhu,et al.  Rapid and label-free detection of breast cancer biomarker CA15-3 in clinical human serum samples with optofluidic ring resonator sensors. , 2009, Analytical chemistry.

[101]  D. Grainger,et al.  Diagnostic devices as biomaterials: a review of nucleic acid and protein microarray surface performance issues , 2008, Journal of biomaterials science. Polymer edition.

[102]  Peter K Sorger,et al.  Microfluidics closes in on point-of-care assays , 2008, Nature Biotechnology.

[103]  R. Bast,et al.  American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[104]  R. Corn,et al.  Microarray methods for protein biomarker detection. , 2008, The Analyst.

[105]  Gwo-Bin Lee,et al.  Screening of Aptamers on Microfluidic Systems for Clinical Applications , 2012, Sensors.

[106]  Adam T Woolley,et al.  Microdevices integrating affinity columns and capillary electrophoresis for multibiomarker analysis in human serum. , 2010, Lab on a chip.

[107]  G. Feldman,et al.  Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2 , 2010, Genetics in Medicine.

[108]  H. Karnes,et al.  Microfluidic immunoaffinity separations for bioanalysis. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[109]  S. Faraoni,et al.  Evaluation of a rapid antigen and antibody combination test in acute HIV infection. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[110]  D. Ransohoff,et al.  Biomarker studies: a call for a comprehensive biomarker study registry , 2011, Nature Reviews Clinical Oncology.

[111]  James F Rusling,et al.  Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. , 2010, The Analyst.

[112]  Marissa N Lassere,et al.  The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints , 2008, Statistical methods in medical research.

[113]  C. Levy,et al.  Influence of renal insufficiency on levels of serum ribonuclease in patients with multiple myeloma. , 1977, Journal of the National Cancer Institute.

[114]  N. Banaei,et al.  Molecular approaches and biomarkers for detection of Mycobacterium tuberculosis. , 2013, Clinics in laboratory medicine.

[115]  Cheryl Moody Bartel,et al.  On-chip aptamer-based sandwich assay for thrombin detection employing magnetic beads and quantum dots. , 2010, Analytical chemistry.

[116]  J. Gallacher,et al.  Childhood Socioeconomic Position and Objectively Measured Physical Capability Levels in Adulthood: A Systematic Review and Meta-Analysis , 2011, PloS one.

[117]  René Bernards,et al.  Taming the dragon: genomic biomarkers to individualize the treatment of cancer , 2011, Nature Medicine.

[118]  Hongyuan Chen,et al.  Lab-on-a-chip for analysis of triglycerides based on a replaceable enzyme carrier using magnetic beads. , 2010, The Analyst.

[119]  Aaron R Wheeler,et al.  Immunoassays in microfluidic systems , 2010, Analytical and bioanalytical chemistry.

[120]  L. Mazutis,et al.  Quantitative and sensitive detection of rare mutations using droplet-based microfluidics. , 2011, Lab on a chip.

[121]  Kathryn A. Phillips,et al.  Diagnostics and biomarker development: priming the pipeline , 2006, Nature Reviews Drug Discovery.

[122]  E. Bottieau,et al.  Evaluation of the malaria rapid diagnostic test SDFK90: detection of both PfHRP2 and Pf-pLDH , 2012, Malaria Journal.

[123]  T. Lyons,et al.  Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. , 2012, Translational research : the journal of laboratory and clinical medicine.

[124]  S. Kaufmann,et al.  Enabling biomarkers for tuberculosis control [State of the Art Series. New tools. Number 3 in the series]. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[125]  Roland Zengerle,et al.  Microfluidic platforms for lab-on-a-chip applications. , 2007, Lab on a chip.

[126]  J. Santiago,et al.  Integrated printed circuit board device for cell lysis and nucleic acid extraction. , 2012, Analytical chemistry.

[127]  S. Zhang,et al.  Chip-based nanoelectrospray mass spectrometry for protein characterization , 2004, Expert review of proteomics.

[128]  Emanuel Carrilho,et al.  Paper-based analytical device for electrochemical flow-injection analysis of glucose in urine. , 2012, Analytical chemistry.

[129]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[130]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[131]  K. Sato,et al.  Synergism between particle-based multiplexing and microfluidics technologies may bring diagnostics closer to the patient , 2008, Analytical and bioanalytical chemistry.

[132]  M. Janković.  Glycans as Biomarkers: Status and Perspectives , 2011 .

[133]  Chun-Yang Zhang,et al.  Single quantum dot-based nanosensor for multiple DNA detection. , 2010, Analytical chemistry.

[134]  Jinghua Yu,et al.  Paper-based three-dimensional electrochemical immunodevice based on multi-walled carbon nanotubes functionalized paper for sensitive point-of-care testing. , 2012, Biosensors & bioelectronics.

[135]  Lithographically patterned silicon nanowire arrays for matrix free LDI-TOF/MS analysis of lipids. , 2010, Lab on a chip.

[136]  O. MacDougald,et al.  Reversibly sealed multilayer microfluidic device for integrated cell perfusion and on-line chemical analysis of cultured adipocyte secretions , 2010, Analytical and bioanalytical chemistry.

[137]  Erik C Jensen,et al.  A digital microfluidic platform for the automation of quantitative biomolecular assays. , 2010, Lab on a chip.

[138]  Marie-Claude Potier,et al.  Analysis of gene expression at the single-cell level using microdroplet-based microfluidic technology. , 2011, Biomicrofluidics.

[139]  Dieter Trau,et al.  Multiplex detection platform for tumor markers and glucose in serum based on a microfluidic microparticle array. , 2012, Analytica chimica acta.

[140]  G. Whitesides.  The origins and the future of microfluidics , 2006, Nature.

[141]  S. Waldman,et al.  Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation , 2007, Clinical pharmacology and therapeutics.

[142]  J. Wiltfang,et al.  Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer’s disease and other neurodegenerative dementias , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[143]  Wang Zhou,et al.  CD4+ T cell count, HIV‐1 viral loads and demographic variables of newly identified patients with HIV infection in Wuhan, China , 2013, Journal of medical virology.

[144]  Alimuddin Zumla,et al.  Immunological biomarkers of tuberculosis , 2011, Nature Reviews Immunology.

[145]  J. Vente,et al.  Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid , 2002, Neurobiology of Aging.

[146]  R. Vasan,et al.  Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations , 2006, Circulation.

[147]  Padma Maruvada,et al.  Metabolomics in biomarker discovery: future uses for cancer prevention. , 2008, Future oncology.

[148]  R. O'Kennedy,et al.  Cardiac biomarkers and the case for point-of-care testing. , 2009, Clinical biochemistry.

[149]  H. Woo,et al.  Current Status of Biomarkers for Prostate Cancer , 2013, International journal of molecular sciences.

[150]  Robert T Kennedy,et al.  Multiplexed detection and applications for separations on parallel microchips , 2008, Electrophoresis.

[151]  Orawon Chailapakul,et al.  A fast and highly sensitive detection of cholesterol using polymer microfluidic devices and amperometric system. , 2011, Talanta.

[152]  D. Fuchs,et al.  Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. , 2007, Diagnostic microbiology and infectious disease.

[153]  G. Meijer,et al.  Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. , 2013, Clinical biochemistry.

[154]  Konstantinos Mitsakakis,et al.  Multi-sample acoustic biosensing microsystem for protein interaction analysis. , 2011, Biosensors & bioelectronics.

[155]  Sylvia Daunert,et al.  Integration of spore-based genetically engineered whole-cell sensing systems into portable centrifugal microfluidic platforms , 2010, Analytical and bioanalytical chemistry.

[156]  G. Mead,et al.  Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia , 2013, Alzheimer's & Dementia.

[157]  Ravi Salgia,et al.  Molecular biomarkers for future screening of lung cancer , 2013, Journal of surgical oncology.

[158]  Steven Gutman,et al.  Opinion: The US Food and Drug Administration perspective on cancer biomarker development , 2006, Nature Reviews Cancer.

[159]  Robert T Kennedy,et al.  Continuous-flow enzyme assay on a microfluidic chip for monitoring glycerol secretion from cultured adipocytes. , 2009, Analytical chemistry.

[160]  Jun‐Jie Zhu,et al.  Microfluidic platform for the evaluation of multi-glycan expressions on living cells using electrochemical impedance spectroscopy and optical microscope. , 2012, Analytical chemistry.